(Q38945636)

English

Neutralizing monoclonal antibodies to human immunodeficiency virus type 1 do not inhibit viral transcytosis through mucosal epithelial cells

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 September 2017

Neutralizing monoclonal antibodies to human immunodeficiency virus type 1 do not inhibit viral transcytosis through mucosal epithelial cells (English)

1 reference

Europe PubMed Central

7 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

monoclonal antibody

1 reference

based on heuristic

inferred from title

Nicolas Chomont

1

object named as

Nicolas Chomont

1 reference

Europe PubMed Central

7 September 2017

author name string

Hakim Hocini

2

1 reference

Europe PubMed Central

7 September 2017

Jean-Chrysostome Gody

3

1 reference

Europe PubMed Central

7 September 2017

Hicham Bouhlal

4

1 reference

Europe PubMed Central

7 September 2017

Pierre Becquart

5

1 reference

Europe PubMed Central

7 September 2017

Corinne Krief-Bouillet

6

1 reference

Europe PubMed Central

7 September 2017

Michel Kazatchkine

7

1 reference

Europe PubMed Central

7 September 2017

Laurent Bélec

8

1 reference

Europe PubMed Central

7 September 2017

language of work or name

0 references

publication date

24 October 2007

1 reference

Europe PubMed Central

7 September 2017

1 reference

Europe PubMed Central

7 September 2017

370

1 reference

Europe PubMed Central

7 September 2017

2

1 reference

Europe PubMed Central

7 September 2017

246-254

1 reference

Europe PubMed Central

7 September 2017

HIV-1 gp41 envelope residues 650-685 exposed on native virus act as a lectin to bind epithelial cell galactosyl ceramide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Secretory IgA specific for a conserved epitope on gp41 envelope glycoprotein inhibits epithelial transcytosis of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Compartmentalization of the IgG immune response to HIV-1 in breast milk

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Secretory anti-human immunodeficiency virus (HIV) antibodies in colostrum and breast milk are not a major determinant of the protection of early postnatal transmission of HIV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Cervicovaginal secretory antibodies to human immunodeficiency virus type 1 (HIV-1) that block viral transcytosis through tight epithelial barriers in highly exposed HIV-1-seronegative African women.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Influence of N-linked glycans in V4-V5 region of human immunodeficiency virus type 1 glycoprotein gp160 on induction of a virus-neutralizing humoral response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Functional and molecular characterization of human monoclonal antibody reactive with the immunodominant region of HIV type 1 glycoprotein 41.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Evaluation of Monoclonal Antibodies to Human Immunodeficiency Virus Type 1 Primary Isolates by Neutralization Assays: Performance Criteria for Selecting Candidate Antibodies for Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

High-level ability of secretory IgA to block HIV type 1 transcytosis: contrasting secretory IgA and IgG responses to glycoprotein 160.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Active and selective transcytosis of cell-free human immunodeficiency virus through a tight polarized monolayer of human endometrial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Neutralization of primary human immunodeficiency virus type 1 isolates: a study of parameters implicated in neutralization in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

The construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

In vitro models of mucosal HIV transmission

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Transmission of human immunodeficiency virus type 1 through breast-feeding: how can it be prevented?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Characterization of human class-switched polymeric (immunoglobulin M [IgM] and IgA) anti-human immunodeficiency virus type 1 antibodies 2F5 and 2G12.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

The antigenic structure of the HIV gp120 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third variable domain.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

based on heuristic

inferred from DOI database lookup

Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

based on heuristic

inferred from DOI database lookup

CD4-Induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

based on heuristic

inferred from DOI database lookup

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.006

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2007.09.006

1 reference

Europe PubMed Central

7 September 2017

1 reference

Europe PubMed Central

7 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38945636&oldid=1797742434"